Index by author

August 01, 1996; Volume 24,Issue 8

B

  1. Ballantyne, B

    1. Pharmacokinetics of ethylene glycol. I. Plasma disposition after single intravenous, peroral, or percutaneous doses in female Sprague-Dawley rats and CD-1 mice.
      S W Frantz, J L Beskitt, C M Grosse, M J Tallant, F K Dietz and B Ballantyne
      Drug Metabolism and Disposition August 1996, 24 (8) 911-921;

  2. Beskitt, J L

    1. Pharmacokinetics of ethylene glycol. I. Plasma disposition after single intravenous, peroral, or percutaneous doses in female Sprague-Dawley rats and CD-1 mice.
      S W Frantz, J L Beskitt, C M Grosse, M J Tallant, F K Dietz and B Ballantyne
      Drug Metabolism and Disposition August 1996, 24 (8) 911-921;

  3. Böcker, R H

    1. In vitro metabolism of atrazine, terbuthylazine, ametryne, and terbutryne in rats, pigs, and humans.
      D Lang, D Criegee, A Grothusen, R W Saalfrank and R H Böcker
      Drug Metabolism and Disposition August 1996, 24 (8) 859-865;

  4. Bort, R

    1. Metabolism of aceclofenac in humans.
      R Bort, X Ponsoda, E Carrasco, M J Gómez-Lechón and J V Castell
      Drug Metabolism and Disposition August 1996, 24 (8) 834-841;

  5. Burchell, B

    1. Reactivity of mefenamic acid 1-o-acyl glucuronide with proteins in vitro and ex vivo.
      K A McGurk, R P Remmel, V P Hosagrahara, D Tosh and B Burchell
      Drug Metabolism and Disposition August 1996, 24 (8) 842-849;

C

  1. Carrasco, E

    1. Metabolism of aceclofenac in humans.
      R Bort, X Ponsoda, E Carrasco, M J Gómez-Lechón and J V Castell
      Drug Metabolism and Disposition August 1996, 24 (8) 834-841;

  2. Castell, J V

    1. Metabolism of aceclofenac in humans.
      R Bort, X Ponsoda, E Carrasco, M J Gómez-Lechón and J V Castell
      Drug Metabolism and Disposition August 1996, 24 (8) 834-841;

  3. Criegee, D

    1. In vitro metabolism of atrazine, terbuthylazine, ametryne, and terbutryne in rats, pigs, and humans.
      D Lang, D Criegee, A Grothusen, R W Saalfrank and R H Böcker
      Drug Metabolism and Disposition August 1996, 24 (8) 859-865;

D

  1. Deger, H M

    1. Biotransformation of the aerosol propellant 1,1,1,2,3,3,3-heptafluoropropane (HFA-227): lack of protein binding of the metabolite hexafluoroacetone.
      U Köster, D Mayer, H M Deger and W DeKant
      Drug Metabolism and Disposition August 1996, 24 (8) 906-910;

  2. DeKant, W

    1. Biotransformation of the aerosol propellant 1,1,1,2,3,3,3-heptafluoropropane (HFA-227): lack of protein binding of the metabolite hexafluoroacetone.
      U Köster, D Mayer, H M Deger and W DeKant
      Drug Metabolism and Disposition August 1996, 24 (8) 906-910;

  3. Dietz, F K

    1. Pharmacokinetics of ethylene glycol. I. Plasma disposition after single intravenous, peroral, or percutaneous doses in female Sprague-Dawley rats and CD-1 mice.
      S W Frantz, J L Beskitt, C M Grosse, M J Tallant, F K Dietz and B Ballantyne
      Drug Metabolism and Disposition August 1996, 24 (8) 911-921;

  4. Ding, X

    1. Expression of CYP2A genes in rodent and human nasal mucosa.
      T Su, J J Sheng, T W Lipinskas and X Ding
      Drug Metabolism and Disposition August 1996, 24 (8) 884-890;

E

  1. Edelman, E R

    1. Local perivascular administration of basic fibroblast growth factor: drug delivery and toxicological evaluation.
      J J Lopez, E R Edelman, A Stamler, J P Morgan, F W Sellke and M Simons
      Drug Metabolism and Disposition August 1996, 24 (8) 922-924;

  2. Ensslin, H K

    1. Metabolism of racemic 3,4-methylenedioxyethylamphetamine in humans. Isolation, identification, quantification, and synthesis of urinary metabolites.
      H K Ensslin, H H Maurer, E Gouzoulis, L Hermle and K A Kovar
      Drug Metabolism and Disposition August 1996, 24 (8) 813-820;

F

  1. Fasco, M J

    1. Expression of cytochromes P450 in human breast tissue and tumors.
      Z Huang, M J Fasco, H L Figge, K Keyomarsi and L S Kaminsky
      Drug Metabolism and Disposition August 1996, 24 (8) 899-905;

  2. Figge, H L

    1. Expression of cytochromes P450 in human breast tissue and tumors.
      Z Huang, M J Fasco, H L Figge, K Keyomarsi and L S Kaminsky
      Drug Metabolism and Disposition August 1996, 24 (8) 899-905;

  3. Frantz, S W

    1. Pharmacokinetics of ethylene glycol. I. Plasma disposition after single intravenous, peroral, or percutaneous doses in female Sprague-Dawley rats and CD-1 mice.
      S W Frantz, J L Beskitt, C M Grosse, M J Tallant, F K Dietz and B Ballantyne
      Drug Metabolism and Disposition August 1996, 24 (8) 911-921;

  4. Fukui, M

    1. Purification and characterization of a medium chain acyl-coenzyme A synthetase.
      F Kasuya, K Igarashi, M Fukui and K Nokihara
      Drug Metabolism and Disposition August 1996, 24 (8) 879-883;

G

  1. Gómez-Lechón, M J

    1. Metabolism of aceclofenac in humans.
      R Bort, X Ponsoda, E Carrasco, M J Gómez-Lechón and J V Castell
      Drug Metabolism and Disposition August 1996, 24 (8) 834-841;

  2. Gouzoulis, E

    1. Metabolism of racemic 3,4-methylenedioxyethylamphetamine in humans. Isolation, identification, quantification, and synthesis of urinary metabolites.
      H K Ensslin, H H Maurer, E Gouzoulis, L Hermle and K A Kovar
      Drug Metabolism and Disposition August 1996, 24 (8) 813-820;

  3. Grosse, C M

    1. Pharmacokinetics of ethylene glycol. I. Plasma disposition after single intravenous, peroral, or percutaneous doses in female Sprague-Dawley rats and CD-1 mice.
      S W Frantz, J L Beskitt, C M Grosse, M J Tallant, F K Dietz and B Ballantyne
      Drug Metabolism and Disposition August 1996, 24 (8) 911-921;

  4. Grothusen, A

    1. In vitro metabolism of atrazine, terbuthylazine, ametryne, and terbutryne in rats, pigs, and humans.
      D Lang, D Criegee, A Grothusen, R W Saalfrank and R H Böcker
      Drug Metabolism and Disposition August 1996, 24 (8) 859-865;

H

  1. Hermle, L

    1. Metabolism of racemic 3,4-methylenedioxyethylamphetamine in humans. Isolation, identification, quantification, and synthesis of urinary metabolites.
      H K Ensslin, H H Maurer, E Gouzoulis, L Hermle and K A Kovar
      Drug Metabolism and Disposition August 1996, 24 (8) 813-820;

  2. Hines, R N

    1. Identification of tissue-specific DNase I hypersensitive sites in the rabbit flavin-containing monooxygenase form 2 gene.
      S E Shehin-Johnson, K C Palmer and R N Hines
      Drug Metabolism and Disposition August 1996, 24 (8) 891-898;

  3. Hosagrahara, V P

    1. Reactivity of mefenamic acid 1-o-acyl glucuronide with proteins in vitro and ex vivo.
      K A McGurk, R P Remmel, V P Hosagrahara, D Tosh and B Burchell
      Drug Metabolism and Disposition August 1996, 24 (8) 842-849;

  4. Huang, Z

    1. Expression of cytochromes P450 in human breast tissue and tumors.
      Z Huang, M J Fasco, H L Figge, K Keyomarsi and L S Kaminsky
      Drug Metabolism and Disposition August 1996, 24 (8) 899-905;

I

  1. Igarashi, K

    1. Purification and characterization of a medium chain acyl-coenzyme A synthetase.
      F Kasuya, K Igarashi, M Fukui and K Nokihara
      Drug Metabolism and Disposition August 1996, 24 (8) 879-883;

K

  1. Kaminsky, L S

    1. Expression of cytochromes P450 in human breast tissue and tumors.
      Z Huang, M J Fasco, H L Figge, K Keyomarsi and L S Kaminsky
      Drug Metabolism and Disposition August 1996, 24 (8) 899-905;

  2. Kasuya, F

    1. Purification and characterization of a medium chain acyl-coenzyme A synthetase.
      F Kasuya, K Igarashi, M Fukui and K Nokihara
      Drug Metabolism and Disposition August 1996, 24 (8) 879-883;

  3. Keyomarsi, K

    1. Expression of cytochromes P450 in human breast tissue and tumors.
      Z Huang, M J Fasco, H L Figge, K Keyomarsi and L S Kaminsky
      Drug Metabolism and Disposition August 1996, 24 (8) 899-905;

  4. Klaassen, C D

    1. Regulation of hepatic sulfotransferases by steroidal chemicals in rats.
      L Liu and C D Klaassen
      Drug Metabolism and Disposition August 1996, 24 (8) 854-858;

  5. Köster, U

    1. Biotransformation of the aerosol propellant 1,1,1,2,3,3,3-heptafluoropropane (HFA-227): lack of protein binding of the metabolite hexafluoroacetone.
      U Köster, D Mayer, H M Deger and W DeKant
      Drug Metabolism and Disposition August 1996, 24 (8) 906-910;

  6. Kovar, K A

    1. Metabolism of racemic 3,4-methylenedioxyethylamphetamine in humans. Isolation, identification, quantification, and synthesis of urinary metabolites.
      H K Ensslin, H H Maurer, E Gouzoulis, L Hermle and K A Kovar
      Drug Metabolism and Disposition August 1996, 24 (8) 813-820;

L

  1. LaBranche, G S

    1. Effects of ethanol and cocaethylene on cocaine pharmacokinetics in conscious dogs.
      R B Parker, C L Williams, S C Laizure, T D Mandrell, G S LaBranche and J J Lima
      Drug Metabolism and Disposition August 1996, 24 (8) 850-853;

  2. Laizure, S C

    1. Effects of ethanol and cocaethylene on cocaine pharmacokinetics in conscious dogs.
      R B Parker, C L Williams, S C Laizure, T D Mandrell, G S LaBranche and J J Lima
      Drug Metabolism and Disposition August 1996, 24 (8) 850-853;

  3. Lang, D

    1. In vitro metabolism of atrazine, terbuthylazine, ametryne, and terbutryne in rats, pigs, and humans.
      D Lang, D Criegee, A Grothusen, R W Saalfrank and R H Böcker
      Drug Metabolism and Disposition August 1996, 24 (8) 859-865;

  4. Lima, J J

    1. Effects of ethanol and cocaethylene on cocaine pharmacokinetics in conscious dogs.
      R B Parker, C L Williams, S C Laizure, T D Mandrell, G S LaBranche and J J Lima
      Drug Metabolism and Disposition August 1996, 24 (8) 850-853;

  5. Lipinskas, T W

    1. Expression of CYP2A genes in rodent and human nasal mucosa.
      T Su, J J Sheng, T W Lipinskas and X Ding
      Drug Metabolism and Disposition August 1996, 24 (8) 884-890;

  6. Liu, L

    1. Regulation of hepatic sulfotransferases by steroidal chemicals in rats.
      L Liu and C D Klaassen
      Drug Metabolism and Disposition August 1996, 24 (8) 854-858;

  7. London, R

    1. Metabolism and toxicity of 4-hydroxyphenylacetone in rat liver slices: comparison with acetaminophen.
      D C Thompson, K Perera and R London
      Drug Metabolism and Disposition August 1996, 24 (8) 866-871;

  8. Lopez, J J

    1. Local perivascular administration of basic fibroblast growth factor: drug delivery and toxicological evaluation.
      J J Lopez, E R Edelman, A Stamler, J P Morgan, F W Sellke and M Simons
      Drug Metabolism and Disposition August 1996, 24 (8) 922-924;

M

  1. Mandrell, T D

    1. Effects of ethanol and cocaethylene on cocaine pharmacokinetics in conscious dogs.
      R B Parker, C L Williams, S C Laizure, T D Mandrell, G S LaBranche and J J Lima
      Drug Metabolism and Disposition August 1996, 24 (8) 850-853;

  2. Marks, G S

    1. Cytochrome P4503A is the major source of N-vinylprotoporphyrin IX formation after administration of 3-[2-(2,4,6-trimethylphenyl)thioethyl]-4-methylsydnone to untreated and dexamethasone-pretreated rats.
      J P McNamee and G S Marks
      Drug Metabolism and Disposition August 1996, 24 (8) 872-878;

  3. Maurer, H H

    1. Metabolism of racemic 3,4-methylenedioxyethylamphetamine in humans. Isolation, identification, quantification, and synthesis of urinary metabolites.
      H K Ensslin, H H Maurer, E Gouzoulis, L Hermle and K A Kovar
      Drug Metabolism and Disposition August 1996, 24 (8) 813-820;

  4. Mayer, D

    1. Biotransformation of the aerosol propellant 1,1,1,2,3,3,3-heptafluoropropane (HFA-227): lack of protein binding of the metabolite hexafluoroacetone.
      U Köster, D Mayer, H M Deger and W DeKant
      Drug Metabolism and Disposition August 1996, 24 (8) 906-910;

  5. McGurk, K A

    1. Reactivity of mefenamic acid 1-o-acyl glucuronide with proteins in vitro and ex vivo.
      K A McGurk, R P Remmel, V P Hosagrahara, D Tosh and B Burchell
      Drug Metabolism and Disposition August 1996, 24 (8) 842-849;

  6. McNamee, J P

    1. Cytochrome P4503A is the major source of N-vinylprotoporphyrin IX formation after administration of 3-[2-(2,4,6-trimethylphenyl)thioethyl]-4-methylsydnone to untreated and dexamethasone-pretreated rats.
      J P McNamee and G S Marks
      Drug Metabolism and Disposition August 1996, 24 (8) 872-878;

  7. Morgan, J P

    1. Local perivascular administration of basic fibroblast growth factor: drug delivery and toxicological evaluation.
      J J Lopez, E R Edelman, A Stamler, J P Morgan, F W Sellke and M Simons
      Drug Metabolism and Disposition August 1996, 24 (8) 922-924;

N

  1. Nokihara, K

    1. Purification and characterization of a medium chain acyl-coenzyme A synthetase.
      F Kasuya, K Igarashi, M Fukui and K Nokihara
      Drug Metabolism and Disposition August 1996, 24 (8) 879-883;

P

  1. Palmer, K C

    1. Identification of tissue-specific DNase I hypersensitive sites in the rabbit flavin-containing monooxygenase form 2 gene.
      S E Shehin-Johnson, K C Palmer and R N Hines
      Drug Metabolism and Disposition August 1996, 24 (8) 891-898;

  2. Pang, K S

    1. Sequestered endoplasmic reticulum space for sequential metabolism of salicylamide. Coupling of hydroxylation and glucuronidation.
      R G Tirona and K S Pang
      Drug Metabolism and Disposition August 1996, 24 (8) 821-833;

  3. Parker, R B

    1. Effects of ethanol and cocaethylene on cocaine pharmacokinetics in conscious dogs.
      R B Parker, C L Williams, S C Laizure, T D Mandrell, G S LaBranche and J J Lima
      Drug Metabolism and Disposition August 1996, 24 (8) 850-853;

  4. Perera, K

    1. Metabolism and toxicity of 4-hydroxyphenylacetone in rat liver slices: comparison with acetaminophen.
      D C Thompson, K Perera and R London
      Drug Metabolism and Disposition August 1996, 24 (8) 866-871;

  5. Ponsoda, X

    1. Metabolism of aceclofenac in humans.
      R Bort, X Ponsoda, E Carrasco, M J Gómez-Lechón and J V Castell
      Drug Metabolism and Disposition August 1996, 24 (8) 834-841;

R

  1. Remmel, R P

    1. Reactivity of mefenamic acid 1-o-acyl glucuronide with proteins in vitro and ex vivo.
      K A McGurk, R P Remmel, V P Hosagrahara, D Tosh and B Burchell
      Drug Metabolism and Disposition August 1996, 24 (8) 842-849;

S

  1. Saalfrank, R W

    1. In vitro metabolism of atrazine, terbuthylazine, ametryne, and terbutryne in rats, pigs, and humans.
      D Lang, D Criegee, A Grothusen, R W Saalfrank and R H Böcker
      Drug Metabolism and Disposition August 1996, 24 (8) 859-865;

  2. Sellke, F W

    1. Local perivascular administration of basic fibroblast growth factor: drug delivery and toxicological evaluation.
      J J Lopez, E R Edelman, A Stamler, J P Morgan, F W Sellke and M Simons
      Drug Metabolism and Disposition August 1996, 24 (8) 922-924;

  3. Shehin-Johnson, S E

    1. Identification of tissue-specific DNase I hypersensitive sites in the rabbit flavin-containing monooxygenase form 2 gene.
      S E Shehin-Johnson, K C Palmer and R N Hines
      Drug Metabolism and Disposition August 1996, 24 (8) 891-898;

  4. Sheng, J J

    1. Expression of CYP2A genes in rodent and human nasal mucosa.
      T Su, J J Sheng, T W Lipinskas and X Ding
      Drug Metabolism and Disposition August 1996, 24 (8) 884-890;

  5. Simons, M

    1. Local perivascular administration of basic fibroblast growth factor: drug delivery and toxicological evaluation.
      J J Lopez, E R Edelman, A Stamler, J P Morgan, F W Sellke and M Simons
      Drug Metabolism and Disposition August 1996, 24 (8) 922-924;

  6. Stamler, A

    1. Local perivascular administration of basic fibroblast growth factor: drug delivery and toxicological evaluation.
      J J Lopez, E R Edelman, A Stamler, J P Morgan, F W Sellke and M Simons
      Drug Metabolism and Disposition August 1996, 24 (8) 922-924;

  7. Su, T

    1. Expression of CYP2A genes in rodent and human nasal mucosa.
      T Su, J J Sheng, T W Lipinskas and X Ding
      Drug Metabolism and Disposition August 1996, 24 (8) 884-890;

T

  1. Tallant, M J

    1. Pharmacokinetics of ethylene glycol. I. Plasma disposition after single intravenous, peroral, or percutaneous doses in female Sprague-Dawley rats and CD-1 mice.
      S W Frantz, J L Beskitt, C M Grosse, M J Tallant, F K Dietz and B Ballantyne
      Drug Metabolism and Disposition August 1996, 24 (8) 911-921;

  2. Thompson, D C

    1. Metabolism and toxicity of 4-hydroxyphenylacetone in rat liver slices: comparison with acetaminophen.
      D C Thompson, K Perera and R London
      Drug Metabolism and Disposition August 1996, 24 (8) 866-871;

  3. Tirona, R G

    1. Sequestered endoplasmic reticulum space for sequential metabolism of salicylamide. Coupling of hydroxylation and glucuronidation.
      R G Tirona and K S Pang
      Drug Metabolism and Disposition August 1996, 24 (8) 821-833;

  4. Tosh, D

    1. Reactivity of mefenamic acid 1-o-acyl glucuronide with proteins in vitro and ex vivo.
      K A McGurk, R P Remmel, V P Hosagrahara, D Tosh and B Burchell
      Drug Metabolism and Disposition August 1996, 24 (8) 842-849;

W

  1. Williams, C L

    1. Effects of ethanol and cocaethylene on cocaine pharmacokinetics in conscious dogs.
      R B Parker, C L Williams, S C Laizure, T D Mandrell, G S LaBranche and J J Lima
      Drug Metabolism and Disposition August 1996, 24 (8) 850-853;
Back to top

In this issue